Published in Arch Surg on November 01, 2003
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol (2011) 3.88
The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg (2013) 2.36
Impact of surgery on quality of life in patients with hepatocellular carcinoma. World J Surg (2014) 2.06
Surgical management of hilar cholangiocarcinoma. Ann Surg (2005) 1.80
Laparoscopic resection for hepatocellular carcinoma: a matched-pair comparative study. Surg Endosc (2009) 1.78
Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford) (2009) 1.70
Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg (2005) 1.69
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg (2006) 1.64
Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) (2011) 1.56
Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48
Applicability of enhanced recovery program for advanced liver surgery. World J Surg (2014) 1.48
Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg (2007) 1.43
Liver volumetry plug and play: do it yourself with ImageJ. World J Surg (2007) 1.34
Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg (2011) 1.29
Current techniques of liver transection. HPB (Oxford) (2007) 1.22
Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol (2012) 1.20
Portal hypertension: contraindication to liver surgery? World J Surg (2006) 1.18
Inflammatory pseudotumor of the liver: a case report and review of the literature. J Med Case Rep (2011) 1.18
Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections. J Gastrointest Surg (2012) 1.14
2012 Liver resections in the 21st century: we are far from zero mortality. HPB (Oxford) (2013) 1.07
Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol (2011) 1.06
Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB (Oxford) (2005) 1.04
A worldwide survey of the current daily practice in liver surgery. Liver Cancer (2013) 1.04
Surgical treatment of hepatocellular carcinoma. HPB (Oxford) (2005) 1.04
Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. PLoS One (2012) 1.03
A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford) (2011) 1.03
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg (2012) 1.02
Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients. World J Gastroenterol (2012) 1.01
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol (2011) 1.00
Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy. Ann Surg (2006) 1.00
Parenchyma-preserving hepatic resection for colorectal liver metastases. Langenbecks Arch Surg (2011) 0.99
Management of excluded segmental bile duct leakage following liver resection. HPB (Oxford) (2009) 0.99
Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors. Liver Int (2012) 0.98
Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg (2014) 0.98
Surgical treatment of hepatocellular carcinoma. Surg Today (2009) 0.97
Safety of liver resections in obese and overweight patients. World J Surg (2010) 0.96
Total or partial anatomical resection of segment 8 using the ultrasound-guided finger compression technique. HPB (Oxford) (2011) 0.96
Appraisal of surgical treatment for pulmonary metastasis from hepatocellular carcinoma. World J Surg (2005) 0.95
Topical haemostatic agents in liver surgery: do we need them? HPB (Oxford) (2009) 0.95
Impact of the VIO system in hepatic resection for patients with hepatocellular carcinoma. Surg Today (2012) 0.95
Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? World J Gastroenterol (2011) 0.94
Comparison of liver parenchymal ablation and tissue necrosis in a cadaveric bovine model using the Harmonic Scalpel, the LigaSure, the Cavitron Ultrasonic Surgical Aspirator and the Aquamantys devices. HPB (Oxford) (2012) 0.93
Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation. J Cancer Res Clin Oncol (2010) 0.92
Volume reduction surgery for advanced hepatocellular carcinoma. J Cancer Res Clin Oncol (2004) 0.92
Hepatic resection for post-cholecystectomy bile duct injuries: a literature review. HPB (Oxford) (2010) 0.91
Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma. Medicine (Baltimore) (2015) 0.91
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) (2010) 0.90
Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. J Am Coll Surg (2010) 0.90
Bile duct leaks from the intrahepatic biliary tree: a review of its etiology, incidence, and management. HPB Surg (2012) 0.90
Feasibility of liver resection without the use of the routine Pringle manoeuver: an analysis of 248 consecutive cases. HPB (Oxford) (2009) 0.89
Anatomic segmental resection compared to major hepatectomy in the treatment of liver neoplasms. HPB (Oxford) (2005) 0.89
Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension. PLoS One (2014) 0.89
Central hepatectomy for centrally located malignant liver tumors: A systematic review. World J Hepatol (2014) 0.89
Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB (Oxford) (2010) 0.88
Liver resection in obese patients: results of a case-control study. HPB (Oxford) (2010) 0.87
Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg (2009) 0.86
Predictive factors for bile leakage after hepatectomy: analysis of 505 consecutive patients. World J Surg (2011) 0.86
A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery. HPB (Oxford) (2010) 0.86
Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score. World J Surg (2015) 0.86
Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality. Ann Surg (2015) 0.86
Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol (2015) 0.85
Anterior vs conventional approach hepatectomy for large liver cancer: a meta-analysis. World J Gastroenterol (2014) 0.85
National trends in discharge disposition after hepatic resection for malignancy. HPB (Oxford) (2011) 0.85
Liver tissue sparing resection using a novel planning tool. Langenbecks Arch Surg (2010) 0.85
Variable Pringle Maneuvers and Effect on Intestinal Epithelium in Rats. A Pilot Experimental Study in Rats. PLoS One (2015) 0.85
Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells. Clin Exp Metastasis (2007) 0.85
Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis. Surg Today (2013) 0.85
Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience. Semin Intervent Radiol (2008) 0.85
Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resection. World J Surg (2012) 0.85
Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysis. Surg Today (2011) 0.84
Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma. World J Surg (2006) 0.84
Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery. HPB (Oxford) (2015) 0.84
Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma. HPB (Oxford) (2009) 0.84
Hemorrhage control for laparoscopic hepatectomy: technical details and predictive factors for intraoperative blood loss. Surg Endosc (2015) 0.83
New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement. World J Surg (2006) 0.83
Novel prediction score including pre- and intraoperative parameters best predicts acute kidney injury after liver surgery. World J Surg (2013) 0.83
Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. World J Gastroenterol (2010) 0.82
Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg (2006) 0.82
Clinical Impact of Anatomical Liver Resection for Hepatocellular Carcinoma with Pathologically Proven Portal Vein Invasion. World J Surg (2016) 0.81
External validation of a pre-operative nomogram predicting peri-operative mortality risk after liver resections for malignancy. HPB (Oxford) (2011) 0.81
Milestones in the evolution of hepatic surgery. Rambam Maimonides Med J (2011) 0.80
Using a 'no drain' policy in 342 laparoscopic hepatectomies: which factors predict failure? HPB (Oxford) (2013) 0.80
IVC CLAMP: infrahepatic inferior vena cava clamping during hepatectomy--a randomised controlled trial in an interdisciplinary setting. Trials (2009) 0.80
Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma. World J Hepatol (2015) 0.80
Association between biliary complications and technique of hilar division (extrahepatic vs. intrahepatic) in major liver resections. World J Surg Oncol (2006) 0.80
Risk factors for incisional and organ space surgical site infections after liver resection are different. World J Surg (2015) 0.80
Liver Resection for Primary Intrahepatic Stones: Focus on Postoperative Infectious Complications. World J Surg (2016) 0.80
Open hepatic parenchymal transection using ultrasonic dissection and bipolar coagulation. HPB (Oxford) (2008) 0.79
Patient preparation before surgery for cholangiocarcinoma. HPB (Oxford) (2008) 0.79
Advances in the surgical treatment of colorectal cancer liver metastases through ultrasound. Surg Today (2011) 0.79
A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes. World J Surg (2005) 0.79
Noninvasive diagnosis of chemotherapy induced liver injury by LiMAx test--two case reports and a review of the literature. BMC Res Notes (2015) 0.79
Inferior right hepatic vein-preserving major right hepatectomy for hepatocellular carcinoma in patients with significant fibrosis or cirrhosis. World J Surg (2014) 0.79
Two hundred and forty-one consecutive liver resections: an experience from India. HPB (Oxford) (2007) 0.79
Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol (2008) 0.79
The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 16.82
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology (2008) 4.61
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med (2002) 4.25
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis (2011) 3.74
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer (2011) 2.81
Marginal survival benefit in the treatment of early hepatocellular carcinoma. J Hepatol (2012) 2.77
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol (2015) 2.70
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol (2008) 2.64
Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer (2009) 2.54
Fluorescent cholangiography using indocyanine green for laparoscopic cholecystectomy: an initial experience. Arch Surg (2009) 2.48
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res (2004) 2.34
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res (2007) 2.29
Portal uptake function in veno-occlusive regions evaluated by real-time fluorescent imaging using indocyanine green. J Hepatol (2012) 2.27
Operative morbidity of living liver donors in Japan. Lancet (2003) 2.13
G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun (2002) 2.13
Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13
Regeneration and function of hemiliver graft: right versus left. Surgery (2006) 2.12
Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol (2013) 2.08
Impact of surgery on quality of life in patients with hepatocellular carcinoma. World J Surg (2014) 2.06
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery (2008) 2.04
Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections. World J Surg (2004) 2.04
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer (2004) 2.03
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01
Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends (2010) 2.01
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg (2012) 1.99
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol (2006) 1.89
The vessel sealing system (LigaSure) in hepatic resection: a randomized controlled trial. Ann Surg (2009) 1.87
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res (2012) 1.84
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg (2007) 1.82
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol (2010) 1.79
Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol (2006) 1.78
Report of the 15th follow-up survey of primary liver cancer. Hepatol Res (2004) 1.78
The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist (2012) 1.76
Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol (2013) 1.76
Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol (2006) 1.72
Acute Appendicitis in an Incarcerated Femoral Hernia: A Case of De Garengeot Hernia. Case Rep Gastroenterol (2009) 1.67
Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery (2003) 1.67
Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey. Liver Transpl (2012) 1.64
Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol (2005) 1.61
Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis (2007) 1.60
Refinement of venous reconstruction using cryopreserved veins in right liver grafts. Liver Transpl (2004) 1.59
Intractable and rare diseases research in Asia. Biosci Trends (2012) 1.59
One orifice vein reconstruction in left liver plus caudate lobe grafts. Transplantation (2007) 1.57
Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol (2006) 1.56
Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) (2011) 1.56
Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg (2005) 1.56
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer (2003) 1.54
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol (2005) 1.52
Portal vein complications after adult-to-adult living donor liver transplantation. Transpl Int (2008) 1.51